Researchers Submit Patent Application, "Methods And Compositions For Prediction Of Therapeutic Efficacy Of Cancer Treatments And Cancer Prognosis", for Approval (USPTO 20240110247).
In: Pharma Business Week, 2024-04-22, S. 1953-1953
serialPeriodical
Zugriff:
A patent application has been submitted for methods and compositions that can predict the effectiveness of cancer treatments and prognosis. The application specifically focuses on the use of a chimeric monoclonal antibody called IMAB362, which targets a molecule found in certain types of cancer. The application also discusses the use of genetic testing to assess a cancer patient's likelihood of responding to antibody treatment and their prognosis. This research has the potential to improve personalized cancer treatment based on genetic markers. [Extracted from the article]
Copyright of Pharma Business Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Methods And Compositions For Prediction Of Therapeutic Efficacy Of Cancer Treatments And Cancer Prognosis", for Approval (USPTO 20240110247).
|
---|---|
Zeitschrift: | Pharma Business Week, 2024-04-22, S. 1953-1953 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6675 (print) |
Schlagwort: |
|
Sonstiges: |
|